정형외과 수술 계획 소프트웨어 시장 : 시장 규모, 점유율, 동향 분석 보고서 - 소프트웨어 제공 형태별, 소프트웨어별, 최종 용도별, 지역별, 부문 예측(2025-2033년)

Orthopedic Surgical Planning Software Market Summary

The global orthopedic surgical planning software market size was estimated at USD 73.49 million in 2024 and is projected to reach USD 131.27 million by 2033, growing at a CAGR of 6.73% from 2025 to 2033, driven by advancements in medical imaging technologies and the increasing adoption of digital solutions in pre- & postoperative care. The rising prevalence of orthopedic disorders such as osteoarthritis, rheumatoid arthritis, and traumatic injuries, coupled with the growing number of joint replacement and spinal surgeries, fuels demand for these solutions.

Enhanced surgical precision, reduced operative time, and improved patient outcomes are key factors driving adoption. In December 2024, Smith+Nephew launched CORIOGRAPH Pre-Op Planning and Modeling Services for total hip arthroplasty, FDA-cleared, for use with the CORI Surgical System. The software enables patient-specific surgical planning using X-rays or CT scans to optimize implant placement and outcomes in orthopedic hip procedures.

As the global population ages, there is a substantial rise in the prevalence of age-related orthopedic conditions, such as osteoarthritis, degenerative joint diseases, fractures, and osteoporosis. As per the WHO report, by the year 2030, one in every six individuals globally will be 60 years or older. At that time, the percentage of the population aged 60 and up will rise from 1 billion in 2020 to 1.4 billion. By the year 2050, the global population of those aged 60 years and above will be twice as large, reaching 2.1 billion. This demographic is particularly vulnerable to orthopedic conditions due to the natural degeneration of bones and joints over time, along with decreased mobility and muscle mass.

The increasing volume of orthopedic procedures creates a significant demand for innovative technologies, such as orthopedic surgical planning software. For instance, information from the 2023 Annual Report of the American Joint Replacement Registry (AJRR) indicates that there were 3,149,042 primary and revision procedures for hip and knee arthroplasty conducted between 2012 and 2022, with primary knee arthroplasty accounting for the majority at 51.0% and primary hip arthroplasty at 33.4%.

Global Orthopedic Surgical Planning Software Market Report Segmentation

This report forecasts revenue growth at global, regional, and country level and provides an analysis on industry trends in each of the sub segments from 2021 to 2033. For this study, Grand View Research, Inc. has segmented the orthopedic surgical planning software market report based on software delivery, software, end use, and region:

• Software Delivery Outlook (Revenue, USD Million, 2021 - 2033)
• Cloud-based
• On-premise
• Software Outlook (Revenue, USD Million, 2021 - 2033)
• Pre-Operative
• Post-Operative
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Orthopedic Clinics
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Spain
  • Italy
  • France
  • Denmark
  • Norway
  • Sweden
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Segment scope
  • 1.1.2. Regional scope
  • 1.1.3. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
• 1.7. Research Assumptions
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Software delivery outlook
  • 2.2.2. Software outlook
  • 2.2.3. End use outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Orthopedic Surgical Planning Software Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Demand for enhanced pre-operative precision
    • 3.2.1.2. Adoption of robotics and navigation-enabled workflows
    • 3.2.1.3. Rising orthopedic surgical adoption across demographics
    • 3.2.1.4. Shift toward patient-specific implants and 3D-printed guides
    • 3.2.1.5. Hospital focus on reducing revisions and improving efficiency
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High implementation costs and limited digital readiness
    • 3.2.2.2. Interoperability challenges across imaging and IT systems
    • 3.2.2.3. Surgeon resistance to transition from conventional techniques
• 3.3. Orthopedic Surgical Planning Software: Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTLE Analysis
• 3.4. Emerging Trends in Orthopedic Surgical Planning Software Market
• 3.5. Investments in Orthopedic Surgical Planning Software Market
• 3.6. Emerging Business Models in Orthopedic Industry
• 3.7. Regulatory Landscape and Compliance

Chapter 4. Orthopedic Surgical Planning Software Market Segment Analysis, By Software Delivery 2021 - 2033 (USD Million)

• 4.1. Definition and Scope
• 4.2. Segment Dashboard
• 4.3. Global orthopedic surgical planning software market, by Software delivery, 2021 to 2033
• 4.4. Cloud-based
  • 4.4.1. Cloud-based market estimates and forecasts, 2021 to 2033 (USD Million)
• 4.5. On-premise
  • 4.5.1. On-premise market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 5. Orthopedic Surgical Planning Software Market Segment Analysis, By Software, 2021 - 2033 (USD Million)

• 5.1. Definition and Scope
• 5.2. Segment Dashboard
• 5.3. Global orthopedic surgical planning software market, by Software, 2021 to 2033
• 5.4. Pre-Operative
  • 5.4.1. Pre-operative market estimates and forecasts, 2021 to 2033 (USD Million)
• 5.5. Post-Operative
  • 5.5.1. Post-operative market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 6. Orthopedic Surgical Planning Software Market Segment Analysis, By End Use, 2021 - 2033 (USD Million)

• 6.1. Definition and Scope
• 6.2. Segment Dashboard
• 6.3. Global orthopedic surgical planning software market, by End Use, 2021 to 2033
• 6.4. Hospitals
  • 6.4.1. Hospitals market estimates and forecasts, 2021 to 2033 (USD Million)
• 6.5. Orthopedic Clinics
  • 6.5.1. Orthopedic clinics market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 7. Orthopedic Surgical Planning Software Market Segment Analysis, By Region, 2021 - 2033 (USD Million)

• 7.1. Regional Market Share Analysis, 2024 & 2033
• 7.2. Regional Market Dashboard
• 7.3. Regional Market Snapshot
• 7.4. Orthopedic Surgical Planning Software Market Share by Region, 2024 & 2033
• 7.5. North America
  • 7.5.1. North America orthopedic surgical planning software market, 2021 - 2033 (USD Million)
  • 7.5.2. U.S.
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Regulatory Framework
    • 7.5.2.3. Competitive Scenario
    • 7.5.2.4. U.S. orthopedic surgical planning software market, 2021 - 2033 (USD Million)
  • 7.5.3. Canada
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Regulatory Framework
    • 7.5.3.3. Competitive Scenario
    • 7.5.3.4. Canada orthopedic surgical planning software market, 2021 - 2033 (USD Million)
  • 7.5.4. Mexico
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Regulatory Framework
    • 7.5.4.3. Competitive Scenario
    • 7.5.4.4. Mexico orthopedic surgical planning software market, 2021 - 2033 (USD Million)
• 7.6. Europe
  • 7.6.1. Europe orthopedic surgical planning software market, 2021 - 2033 (USD Million)
  • 7.6.2. UK
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Regulatory Framework
    • 7.6.2.3. Competitive Scenario
    • 7.6.2.4. UK orthopedic surgical planning software market, 2021 - 2033 (USD Million)
  • 7.6.3. Germany
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Regulatory Framework
    • 7.6.3.3. Competitive Scenario
    • 7.6.3.4. Germany orthopedic surgical planning software market, 2021 - 2033 (USD Million)
  • 7.6.4. France
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Regulatory Framework
    • 7.6.4.3. Competitive Scenario
    • 7.6.4.4. France orthopedic surgical planning software market, 2021 - 2033 (USD Million)
  • 7.6.5. Italy
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Regulatory Framework
    • 7.6.5.3. Competitive Scenario
    • 7.6.5.4. Italy orthopedic surgical planning software market, 2021 - 2033 (USD Million)
  • 7.6.6. Spain
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Regulatory Framework
    • 7.6.6.3. Competitive Scenario
    • 7.6.6.4. Spain orthopedic surgical planning software market, 2021 - 2033 (USD Million)
  • 7.6.7. Norway
    • 7.6.7.1. Key Country Dynamics
    • 7.6.7.2. Regulatory Framework
    • 7.6.7.3. Competitive Scenario
    • 7.6.7.4. Norway orthopedic surgical planning software market, 2021 - 2033 (USD Million)
  • 7.6.8. Sweden
    • 7.6.8.1. Key Country Dynamics
    • 7.6.8.2. Regulatory Framework
    • 7.6.8.3. Competitive Scenario
    • 7.6.8.4. Sweden orthopedic surgical planning software market, 2021 - 2033 (USD Million)
  • 7.6.9. Denmark
    • 7.6.9.1. Key Country Dynamics
    • 7.6.9.2. Regulatory Framework
    • 7.6.9.3. Competitive Scenario
    • 7.6.9.4. Denmark orthopedic surgical planning software market, 2021 - 2033 (USD Million)
• 7.7. Asia Pacific
  • 7.7.1. Japan
    • 7.7.1.1. Key Country Dynamics
    • 7.7.1.2. Regulatory Framework
    • 7.7.1.3. Competitive Scenario
    • 7.7.1.4. Japan orthopedic surgical planning software market, 2021 - 2033 (USD Million)
  • 7.7.2. China
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Regulatory Framework
    • 7.7.2.3. Competitive Scenario
    • 7.7.2.4. China orthopedic surgical planning software market, 2021 - 2033 (USD Million)
  • 7.7.3. India
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Regulatory Framework
    • 7.7.3.3. Competitive Scenario
    • 7.7.3.4. India orthopedic surgical planning software market, 2021 - 2033 (USD Million)
  • 7.7.4. Australia
    • 7.7.4.1. Key Country Dynamics
    • 7.7.4.2. Regulatory Framework
    • 7.7.4.3. Competitive Scenario
    • 7.7.4.4. Australia orthopedic surgical planning software market, 2021 - 2033 (USD Million)
  • 7.7.5. South Korea
    • 7.7.5.1. Key Country Dynamics
    • 7.7.5.2. Regulatory Framework
    • 7.7.5.3. Competitive Scenario
    • 7.7.5.4. South Korea orthopedic surgical planning software market, 2021 - 2033 (USD Million)
  • 7.7.6. Thailand
    • 7.7.6.1. Key Country Dynamics
    • 7.7.6.2. Regulatory Framework
    • 7.7.6.3. Competitive Scenario
    • 7.7.6.4. Thailand orthopedic surgical planning software market, 2021 - 2033 (USD Million)
• 7.8. Latin America
  • 7.8.1. Brazil
    • 7.8.1.1. Key Country Dynamics
    • 7.8.1.2. Regulatory Framework
    • 7.8.1.3. Competitive Scenario
    • 7.8.1.4. Brazil orthopedic surgical planning software market, 2021 - 2033 (USD Million)
  • 7.8.2. Argentina
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Regulatory Framework
    • 7.8.2.3. Competitive Scenario
    • 7.8.2.4. Argentina orthopedic surgical planning software market, 2021 - 2033 (USD Million)
• 7.9. MEA
  • 7.9.1. South Africa
    • 7.9.1.1. Key Country Dynamics
    • 7.9.1.2. Regulatory Framework
    • 7.9.1.3. Competitive Scenario
    • 7.9.1.4. South Africa orthopedic surgical planning software market, 2021 - 2033 (USD Million)
  • 7.9.2. Saudi Arabia
    • 7.9.2.1. Key Country Dynamics
    • 7.9.2.2. Regulatory Framework
    • 7.9.2.3. Competitive Scenario
    • 7.9.2.4. Saudi Arabia orthopedic surgical planning software market, 2021 - 2033 (USD Million)
  • 7.9.3. UAE
    • 7.9.3.1. Key Country Dynamics
    • 7.9.3.2. Regulatory Framework
    • 7.9.3.3. Competitive Scenario
    • 7.9.3.4. UAE orthopedic surgical planning software market, 2021 - 2033 (USD Million)
  • 7.9.4. Kuwait
    • 7.9.4.1. Key Country Dynamics
    • 7.9.4.2. Regulatory Framework
    • 7.9.4.3. Competitive Scenario
    • 7.9.4.4. Kuwait orthopedic surgical planning software market, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company Categorization
• 8.3. Company Market Share Analysis, 2024
• 8.4. Company Profiles
  • 8.4.1. EOS imaging (ATEC)
    • 8.4.1.1. Company overview
    • 8.4.1.2. Financial performance
    • 8.4.1.3. Product benchmarking
    • 8.4.1.4. Strategic initiatives
  • 8.4.2. Formus Labs Ltd
    • 8.4.2.1. Company overview
    • 8.4.2.2. Financial performance
    • 8.4.2.3. Product benchmarking
    • 8.4.2.4. Strategic initiatives
  • 8.4.3. Brainlab AG
    • 8.4.3.1. Company overview
    • 8.4.3.2. Financial performance
    • 8.4.3.3. Product benchmarking
    • 8.4.3.4. Strategic initiatives
  • 8.4.4. mediCAD
    • 8.4.4.1. Company overview
    • 8.4.4.2. Financial performance
    • 8.4.4.3. Product benchmarking
    • 8.4.4.4. Strategic initiatives
  • 8.4.5. PEEK HEALTH S.A.
    • 8.4.5.1. Company overview
    • 8.4.5.2. Financial performance
    • 8.4.5.3. Product benchmarking
    • 8.4.5.4. Strategic initiatives
  • 8.4.6. Radlink Inc.
    • 8.4.6.1. Company overview
    • 8.4.6.2. Financial performance
    • 8.4.6.3. Product benchmarking
    • 8.4.6.4. Strategic initiatives
  • 8.4.7. Corin Group
    • 8.4.7.1. Company overview
    • 8.4.7.2. Financial performance
    • 8.4.7.3. Product benchmarking
    • 8.4.7.4. Strategic initiatives
  • 8.4.8. RSA Biomedical
    • 8.4.8.1. Company overview
    • 8.4.8.2. Financial performance
    • 8.4.8.3. Product benchmarking
    • 8.4.8.4. Strategic initiatives
  • 8.4.9. Enhatch Inc.
    • 8.4.9.1. Company overview
    • 8.4.9.2. Financial performance
    • 8.4.9.3. Product benchmarking
    • 8.4.9.4. Strategic initiatives
  • 8.4.10. DePuy Synthes (Johnson & Johnson Medical Devices Companies)
    • 8.4.10.1. Company overview
    • 8.4.10.2. Financial performance
    • 8.4.10.3. Product benchmarking
    • 8.4.10.4. Strategic initiatives
  • 8.4.11. Zimmer Biomet
    • 8.4.11.1. Company overview
    • 8.4.11.2. Financial performance
    • 8.4.11.3. Product benchmarking
    • 8.4.11.4. Strategic initiatives
  • 8.4.12. Stryker Corporation
    • 8.4.12.1. Company overview
    • 8.4.12.2. Financial performance
    • 8.4.12.3. Product benchmarking
    • 8.4.12.4. Strategic initiatives